title: Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues.
abstract: Regulator of G protein signaling (RGS) proteins act as GTPase-activating proteins (GAPs) for Galpha subunits and negatively regulate G protein-coupled receptor signaling. Using RGS5 gene-specific RT-PCR, we have identified a novel alternative splicing variant of RGS5 mRNA in human ocular tissues. The alternative splicing of RGS5 mRNA occurred at position +44 (GenBank NM_003617), spliced out 174 bp (+44 to +218 bp) of the coding region, and encoded an RGS5s protein with a 108 amino acid N-terminal deletion. This study is the first to document alternative splicing of an RGS5 gene. We therefore studied RGS5 and RGS5s mRNA distribution in human tissues. In the eye, RGS5s was found to be highly expressed in the ciliary body and trabecular meshwork. It was also expressed in the kidney, brain, spleen, skeletal muscle and small intestine, but was not detectable in the liver, lung, heart. RGS5s was not found in monkey and rat ocular tissues, indicating species specificity for the eye. Comparing the recombinant RGS5 and RGS5s expression in HEK293/EBNA cells, RGS5s was present almost exclusively in the cytosolic fraction, whereas RGS5 was present in both membrane and cytosolic fractions. The data suggest that the N-terminal of RGS5 may be important for protein translocation to the cell membrane. Both RGS5 and RGS5s antagonized the rapid phosphorylation of p44/42 MAP kinase induced by Galphai coupled cannibinoid receptor-1 activation. RGS5, but not RGS5s, inhibited the Ca2+ signaling initiated by activation of Galphaq coupled angiotensin II receptors (AT1) and prostaglandin FP receptors. Cotransfection of RGS5s with RGS5 resulted in the blockade of RGS5 actions with respect to inhibition of the signal transduction initiated by activation of both AT1 and FP receptor, suggesting that RGS5s may contain functional domains that compete with RGS5 in the regulation of the Galphaq coupled AT1 and FP receptors. The unique expression pattern, cellular localization and functions of RGS5s suggest that RGS5s may play a critical role in the regulation of intracellular signaling pathways.
authors.affiliation: Department of Biological Science, Allergan, Inc., Irvine, CA 92612, USA. Liang_Yanbin@Allergan.com
authors.forename: Yanbin
authors.initials: Y
authors.lastname: Liang
authors.forename: Chen
authors.initials: C
authors.lastname: Li
authors.forename: Victor M
authors.initials: VM
authors.lastname: Guzman
authors.forename: William W
authors.initials: WW
authors.lastname: Chang
authors.forename: Albert J
authors.initials: AJ
authors.lastname: Evinger
authors.forename: Dyna
authors.initials: D
authors.lastname: Sao
authors.forename: David F
authors.initials: DF
authors.lastname: Woodward
mesh_terms: D017398:Alternative Splicing; D000818:Animals; D001483:Base Sequence; D015153:Blotting, Western; D020013:Calcium Signaling; D002460:Cell Line; D017931:DNA Primers; D005123:Eye / Q000378:metabolism*; D000882:Haplorhini; D006801:Humans; D010957:Plasmids; D020710:RGS Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics*; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D017931:DNA Primers; D020710:RGS Proteins; C491349:RGS5 protein, human; D012333:RNA, Messenger